XML 148 R29.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Segment Information (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Schedule of Operations by Reportable Segment

Approximate information concerning the Company’s operations by reportable segment for the three and six months ended June 30, 2024 and 2023 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein:

 Schedule of Operations by Reportable Segment

Three Months Ended June 30, 2024		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	3,539,000			$	44,000			$	3,000			$	1,000			$	624,000			$	-			$	4,211,000
Cost of Revenue			3,598,000				(4,484,000	)			-				10,000				2,066,000				4,483,000				5,673,000
Depreciation and amortization			190,000				-				34,000				288,000				39,000				4,000				555,000
Interest expense			45,000				-				-				-				1,199,000				-				1,244,000
Interest income			-				(1,000	)			36,000				3,000				156,000				1,000				195,000
Net income (loss) from continuing operations			(894,000	)			502,000				104,000				(669,000	)			(2,566,000	)			(1,431,000	)			(4,954,000	)
Capital expenditures			29,000				-				-				-				-				-				29,000
Identifiable assets			19,683,000				12,129,000				442,000				48,631,000				59,211,000				4,352,000				144,448,000
Assets held for sale			-				-				-				-				46,040,000				-				46,040,000

Three Months Ended June 30,2023		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	3,626,000			$	197,000			$	1,572,000			$	-			$	1,838,000			$	-			$	7,233,000
Cost of Revenue			2,421,000				-				516,000				2,000				1,820,000				73,000				4,832,000
Depreciation and amortization			193,000				-				43,000				289,000				782,000				7,000				1,314,000
Interest expense			47,000				-				-				-				91,000				-				138,000
Interest income			-				-				280,000				49,000				78,000								407,000
Net income (loss) from continuing operations			(205,000	)			(1,213,000	)			(28,074,000	)			(3,934,000	)			(4,413,000	)			116,000				(37,723,000	)
Capital expenditures			4,000				-				(4,000	)			12,000				7,000				-				19,000
Identifiable assets			23,080,000				41,324,000				7,159,000				49,952,000				71,610,000				9,619,000				202,744,000
Assets held for sale			-				-				2,004,000				-				-				-				2,004,000

Six Months Ended June 30, 2024		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	6,620,000			$	146,000			$	3,000			$	2,000			$	1,311,000			$	-			$	8,082,000
Cost of Revenue			6,365,000				(4,015,000	)			-				20,000				3,810,000				4,483,000				10,663,000
Depreciation and amortization			381,000				-				68,000				577,000				107,000				3,000				1,136,000
Interest expense			91,000				-				-				-				2,299,000				-				2,390,000
Interest income			-				-				72,000				9,000				219,000				2,000				302,000
Net income (loss) from continuing operations			(1,367,000	)			(880,000	)			34,000				(1,610,000	)			(4,915,000	)			(1,325,000	)			(10,063,000	)
Capital expenditures			29,000				-				-				-				-				-				29,000
Total Identifiable assets			19,683,000				12,129,000				442,000				48,631,000				59,211,000				4,352,000				144,448,000
Assets held for sale			-				-				-				-				46,040,000				-				46,040,000

Six Months Ended June 30,2023		Product Packaging				Commercial Lending				Direct Marketing				Biotechnology				Securities				Corporate				Total
Revenue		$	9,661,000			$	314,000			$	5,566,000			$	-			$	3,523,000			$	-			$	19,064,000
Cost of revenue			7,081,000				-				1,806,000				63,000				4,340,000				75,000				13,365,000
Depreciation and amortization			381,000				-				89,000				586,000				1,526,000				65,000				2,647,000
Interest expense			86,000				-				-				-				302,000				-				388,000
Interest income			-				-				285,000				143,000				110,000				-				538,000
Net income (loss) from continuing operations			491,000				(1,777,000	)			(31,260,000	)			(4,782,000	)			(6,441,000	)			(2,588,000	)			(46,357,000	)
Capital expenditures			580,000				-				-				17,000				35,000				(19,000	)			613,000
Identifiable assets			23,080,000				41,324,000				7,159,000				49,952,000				71,610,000				9,619,000				202,744,000
Assets held for sale			-				-				2,004,000				-				-				-				2,004,000

Schedule of Disaggregation of Revenue

The following tables disaggregate our business segment revenues by major source:

Printed Products Revenue Information:

Schedule of Disaggregation of Revenue

Three months ended June 30, 2024
Packaging Printing and Fabrication		$	3,441,000
Commercial and Security Printing			87,000
Total Printed Products		$	3,528,000

Three months ended June 30, 2023
Packaging Printing and Fabrication		$	3,571,000
Commercial and Security Printing			55,000
Total Printed Products		$	3,626,000

Six months ended June 30, 2024
Packaging Printing and Fabrication		$	6,323,000
Commercial and Security Printing			278,000
Total Printed Products		$	6,601,000

Six months ended June 30, 2023
Packaging Printing and Fabrication		$	9,341,000
Commercial and Security Printing			320,000
Total Printed Products		$	9,661,000

Direct Marketing

Three months ended June 30, 2024
Direct Marketing Internet Sales		$	-
Total Direct Marketing		$	-

Three months ended June 30, 2023
Direct Marketing Internet Sales		$	1,572,000
Total Direct Marketing		$	1,572,000

Six months ended June 30, 2024
Direct Marketing Internet Sales		$	-
Total Direct Marketing		$	-

Six months ended June 30, 2023
Direct Marketing Internet Sales		$	5,566,000
Total Direct Marketing		$	5,566,000

Rental Income

Three months ended June 30, 2024
Rental income		$	438,000
Total Rental Income		$	438,000
Three months ended June 30, 2023
Rental income		$	1,543,000
Total Rental Income		$	1,543,000

Six months ended June 30, 2024
Rental income		$	838,000
Total Rental Income		$	838,000

Six months ended June 30, 2023
Rental income		$	3,228,000
Total Rental Income		$	3,228,000

Commission Income

Three months ended June 30, 2024
Commission income		$	204,000
Total commission income		$	204,000

Three months ended June 30, 2023
Commission income		$	295,000
Total commission income		$	295,000

Six months ended June 30, 2024
Commission income		$	507,000
Total commission income		$	507,000

Six months ended June 30, 2023
Commission income		$	295,000
Total commission income		$	295,000

Net Investment Income

Three months ended June 30, 2024
Net Investment Income		$	41,000
Total Investment Income		$	41,000

Three months ended June 30, 2023
Net Investment Income		$	197,000
Total Rental Income		$	197,000

Six months ended June 30, 2024
Net investment income		$	136,000
Total Management fee income		$	136,000

Six months ended June 30, 2023
Net Investment Income		$	314,000
Total Management fee income		$	314,000

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration